LifeScan recalls lots of glucose test strips
MILPITAS, Calif. LifeScan on Wednesday issued a voluntary recall in the United States of eight lots of OneTouch SureStep test strips, used by people with diabetes to measure their blood glucose levels at home.
The test strips are being recalled because they may provide falsely low glucose results when the glucose level is higher than 400 mg/dL, Johnson & Johnson stated. LifeScan estimated approximately 14,000 packages (50- and 100-count) of consumer OneTouch SureStep Test Strips were distributed nationwide between Aug. 1, 2009, and Jan. 28, 2010.
Patients with test strips from the recalled lots are asked to call LifeScan at 1-800 574-6139 between 5:00 am and 7:00 pm Pacific Time, seven days a week or visit www.SureStep.com to request replacement product. Replacement product will be shipped immediately and provided free of charge.
The eight lots of consumer OneTouch SureStep Test Strips being recalled are:Recalled Lot Size Description # 2969251 100-ct OneTouch SureStep# 2969798 100-ct OneTouch SureStep# 2982369 100-ct OneTouch SureStep# 2983467 100-ct OneTouch SureStep# 2969795 50-ct OneTouch SureStep# 2982566 50-ct OneTouch SureStep# 2969481 50-ct Medicare/Mail Order# 2998193 50-ct Medicare/Mail Order
Lot #’s are located on the outer carton and test strip vial.
Study finds Ulesfia effectively kills head lice
HOBOKEN, N.J. A new non-neurotoxic treatment for head lice has been found to have an average of 91.2% treatment success rate after one week, and to be safe in humans from 6 months of age and up, according to a study published in the latest issue of Pediatric Dermatology.
Benzyl Alcohol Lotion 5% (branded Ulesfia) works by suffocating lice. Unlike commonly used asphyxiant remedies, scanning electron microscopy appears to indicate that benzyl alcohol lotion effectively asphyxiates lice by “stunning” the spiracles open, allowing the lotion, comprised of mineral oil and other inactive ingredients, to infiltrate the “honeycomb” respiratory apparatus and kill lice.
“Existing over-the-counter head lice treatments contain neurotoxic pesticides as active ingredients, resulting in potential toxicity and other problems, including lengthy applications, odor, ineffective treatment,” stated study author Terri Meinking of Global Health Associates. “Resistance has also become a problem now that lice have had such prolonged exposure to these products.”
Stopain partners with Arthritis Foundation
ENCINITAS, Calif. DRJ Group, the makers of Stopain topical analgesics, on Tuesday announced that new product packaging labels showing the company’s support for the Arthritis Foundation will begin appearing on store shelves.
The labels read, in part, “Your purchase benefits the Arthritis Foundation. For every unit of Stopain products sold, DRJ Group will donate a portion of the proceeds to the Arthritis Foundation with a minimum contribution of $25,000 to help people take control of arthritis.”
The new label messaging is part the company’s year-long awareness and fundraising initiative with the Arthritis Foundation.
As part of the initiative, DRJ Group released a video in cooperation with the Arthritis Foundation –– Stop Pain. Start Dancing –– which stars motivational speaker and dancer, Judson Laipply. The video was designed to help spread the message that staying active has long-term health benefits, including managing the effects of arthritis.